Setting a New Standard of Excellence
Acquiring a Network of Laboratory Systems and Services to Deliver on the Promise of Precision
About Labarium
Our History
Established by leading executives in the field of molecular diagnostics, pain management and addiction research, Labarium seeks to grow through strategic acquisitions of high-performing, compliant clinical laboratories across the United States to deliver its proprietary platforms to address the Nation's most prevalent and expensive health condition, as well as the leading cause of preventable death.
Our Private Equity Partner
Labarium has partnered with an investment bank, Crewe Capital, to fund its acquisitions. Crewe has a carefully curated team of experienced investment bankers providing clients with full-service advisory, with a focus on selling middle-market businesses. Investment banking and merger and acquisition experts add value to firm clients in both their operating businesses and investment portfolios. Our professionals have advised on hundreds of transactions, aggregating approximately $70 billion in total value
Contact Us
Let's Discuss How You Can Join Us
We are looking to acquire or partner with clinical laboratories across the United States.
